In the latest session, Virios Therapeutics Inc (NASDAQ: VIRI) closed at $0.33 up 6.27% from its previous closing price of $0.31. In other words, the price has increased by $+0.0196 from its previous closing price. On the day, 674243 shares were traded.
Ratios:
For a deeper understanding of Virios Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.62 and its Current Ratio is at 11.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 21 when Pridgen William bought 15,335 shares for $1.30 per share. The transaction valued at 19,992 led to the insider holds 52,045 shares of the business.
Duncan Gregory Scott bought 25,000 shares of VIRI for $31,245 on Aug 17. The CHIEF EXECUTIVE OFFICER now owns 57,461 shares after completing the transaction at $1.25 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIRI now has a Market Capitalization of 6.64M and an Enterprise Value of 3.33M.
Stock Price History:
Over the past 52 weeks, VIRI has reached a high of $2.42, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 0.4945, while the 200-Day Moving Average is calculated to be 0.9890.
Shares Statistics:
For the past three months, VIRI has traded an average of 239.27K shares per day and 187.24k over the past ten days. A total of 18.33M shares are outstanding, with a floating share count of 14.86M. Insiders hold about 22.83% of the company’s shares, while institutions hold 4.47% stake in the company. Shares short for VIRI as of Feb 15, 2024 were 152.27k with a Short Ratio of 0.64, compared to 224.89k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.79% and a Short% of Float of 0.84%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.05, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.21 and -$0.37 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.35, with 2 analysts recommending between -$0.32 and -$0.39.
